| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 4.852 | 7.315 | 9.798 | 13.745 | 22.392 | 36.255 | 48.739 | 81.505 |
| Total Income - EUR | - | - | 4.852 | 7.315 | 9.799 | 13.747 | 22.408 | 38.219 | 48.739 | 81.505 |
| Total Expenses - EUR | - | - | 1.810 | 8.849 | 7.785 | 10.421 | 16.822 | 24.844 | 43.751 | 74.701 |
| Gross Profit/Loss - EUR | - | - | 3.042 | -1.534 | 2.014 | 3.326 | 5.586 | 13.375 | 4.989 | 6.804 |
| Net Profit/Loss - EUR | - | - | 2.897 | -1.754 | 1.720 | 2.953 | 5.015 | 12.752 | 4.613 | 4.677 |
| Employees | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Chd Pathologia Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 4 | 14.689 | 12.587 | 28.647 | 32.060 | 27.180 | 38.355 |
| Current Assets | - | - | 4.168 | 1.408 | 2.055 | 1.241 | 1.065 | 5.622 | 3.458 | 8.612 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 2.680 | 622 | 1.025 |
| Receivables | - | - | 387 | 120 | 619 | 297 | 655 | 709 | 587 | 1.308 |
| Cash | - | - | 3.780 | 1.287 | 1.436 | 944 | 410 | 2.233 | 2.249 | 6.278 |
| Shareholders Funds | - | - | 2.941 | 1.133 | 2.831 | 5.730 | 10.618 | 23.402 | 25.747 | 29.187 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 1.227 | 279 | 13.913 | 8.098 | 19.256 | 14.443 | 5.945 | 18.024 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Chd Pathologia Srl